Clinical assessment of ChAdOx1 vectored vaccines against emerging pathogens
<p>Traditional vaccine development strategies are costly and time-consuming which makes them unsuitable for clinical assessment of new vaccines in the context of infectious diseases outbreaks. Platform technologies provide substantial manufacturing advantages and have the potential to signific...
Автор: | Moreira Folegatti, P |
---|---|
Інші автори: | Gilbert, S |
Формат: | Дисертація |
Мова: | English |
Опубліковано: |
2021
|
Предмети: |
Схожі ресурси
Схожі ресурси
-
Stability of Chimpanzee Adenovirus Vectored Vaccines (ChAdOx1 and ChAdOx2) in Liquid and Lyophilised Formulations
за авторством: Adam Berg, та інші
Опубліковано: (2021-10-01) -
Effect of Prior ChAdOx1 COVID-19 Immunisation on T-Cell Responses to ChAdOx1-HBV
за авторством: Charlotte Davis, та інші
Опубліковано: (2024-06-01) -
Lyophilization to enable distribution of ChAdOx1 and ChAdOx2 adenovirus-vectored vaccines without refrigeration
за авторством: Zhang, C, та інші
Опубліковано: (2023) -
Lyophilization to enable distribution of ChAdOx1 and ChAdOx2 adenovirus-vectored vaccines without refrigeration
за авторством: Cheng Zhang, та інші
Опубліковано: (2023-06-01) -
An exploratory analysis of the response to ChAdOx1 nCoV-19 (AZD1222) vaccine in males and females
за авторством: Natalie Gabrielle Marchevsky, та інші
Опубліковано: (2022-07-01)